Genetic products differentially expressed in tumors and the use thereof

Details for Australian Patent Application No. 2010202440 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Koslowski, Michael; Tureci, Ozlem; Sahin, Ugur

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2010202440

Parent 2003282101

Filing date 10 June 2010

Wipo publication date 1 July 2010

Acceptance publication date 1 November 2012

International Classifications

C07K 14/47 Peptides having more than 20 amino acids

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 39/00 Medicinal preparations containing antigens or antibodies

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 July 2010 Application Open to Public Inspection

  Published as AU-B-2010202440

1 July 2010 Complete Application Filed

1 November 2012 Application Accepted

  Published as AU-B-2010202440

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202441-Drop gear drive box incorporating a power divider

2010202436-Automobile seat for children, intended to equip an automobile vehicle seat